The home health and hospice landscape is undergoing significant shifts, with BrightSpring Health Services (Nasdaq: BTSG) poised for substantial growth following its recent acquisitions. The Louisville, Kentucky-based company is integrating a portfolio of 107 home health and hospice assets, acquired from UnitedHealth Group (NYSE: UNH) and Amedisys, for $239 million. This strategic move, finalized after UnitedHealth Group’s acquisition of Amedisys in August 2025, signals BrightSpring’s confidence in the expanding demand for in-home care and its commitment to becoming a leading provider in this sector. The company anticipates these newly acquired locations will contribute significantly to its financial performance in 2026.
BrightSpring’s expansion isn’t simply about adding locations; it’s about consolidating a fragmented market and leveraging economies of scale. The acquired assets, some of which previously belonged to LHC Group – itself acquired by UnitedHealth Group in 2023 – complement BrightSpring’s existing geographic footprint and align with its established hospice locations. This strategic alignment allows for more efficient resource allocation and a broader service offering to patients across the United States. The company currently serves over 400,000 patients daily across all 50 states, providing a comprehensive range of services including hospice, home health, primary care, rehabilitation, pharmaceuticals, and behavioral health care.
BrightSpring’s Financial Performance and Growth Strategy
The acquisition is expected to be accretive to BrightSpring’s earnings in 2026, according to company leadership. The acquired locations generated a pro forma revenue of $345 million in 2025, even factoring in the period before the transactions officially closed. Hospice News reported on the expected financial benefits of the deal. This revenue boost is part of a larger trend of strong financial performance for BrightSpring. In the fourth quarter of 2025, the company’s provider services segment earned $394 million, a significant increase from $350 million in the same period the previous year. For the full year 2025, this segment brought in nearly $1.5 billion, up from $1.3 billion in 2024 – representing an 11% growth rate.
BrightSpring’s consolidated revenue for the fourth quarter of 2025 reached approximately $3.6 million, a nearly 30% increase compared to the fourth quarter of 2024. This impressive growth is fueled by increasing demand for home- and community-based healthcare services, a trend accelerated by an aging population and a growing preference for receiving care in the comfort of one’s own home. The company is actively investing in its sales teams across all segments, including home health and hospice, to capitalize on this growing market. BrightSpring is implementing Lean Six Sigma practices and leveraging artificial intelligence to enhance operational efficiency and drive further growth.
The Expanding Role of Home Health and Hospice Care
The demand for home health and hospice services is projected to continue rising in the coming years, driven by demographic shifts and evolving healthcare preferences. According to BrightSpring CEO Jon Rousseau, the company sees an “unbelievable runway” for growth in these areas over the next five to ten years. Hospice currently represents approximately two-thirds of BrightSpring’s home health segment, demonstrating its importance to the company’s overall success. The company’s focus on both hospice and home health allows it to provide a continuum of care, meeting patients’ needs at various stages of their health journey.
The integration of the Amedisys and LHC Group assets is expected to accelerate this growth. Rousseau emphasized that these assets are “very complementary” to BrightSpring’s existing home health business, both geographically and in terms of market presence. The company is actively working to integrate these novel operations, bringing its established capabilities and best practices to the acquired locations. This includes leveraging technology, enhancing sales strategies, and improving overall service delivery. BrightSpring’s commitment to innovation and continuous improvement positions it well to capitalize on the opportunities presented by the expanding home health and hospice market.
Leveraging Technology and Efficiency
BrightSpring isn’t relying solely on organic growth, and acquisitions. The company is actively investing in technology and process improvements to enhance efficiency and improve patient care. The implementation of Lean Six Sigma methodologies, a data-driven approach to process improvement, is aimed at streamlining operations and reducing waste. Home Healthcare News highlighted the company’s focus on these initiatives. The company is exploring the use of artificial intelligence (AI) to automate tasks, improve decision-making, and personalize patient care. These technological advancements are expected to play a crucial role in BrightSpring’s future success.
The company’s investment in technology extends to its sales teams as well. By equipping its sales representatives with advanced tools and data analytics, BrightSpring aims to improve lead generation, enhance customer engagement, and drive revenue growth. This data-driven approach to sales is expected to be particularly effective in the competitive home health and hospice market. The company’s commitment to innovation and technology underscores its dedication to providing high-quality, efficient, and patient-centered care.
Looking Ahead: BrightSpring’s Position in the Market
BrightSpring’s recent acquisitions and strategic investments position it as a major player in the rapidly evolving home health and hospice market. The company’s comprehensive service offering, extensive geographic reach, and commitment to innovation give it a competitive advantage. As the demand for in-home care continues to grow, BrightSpring is well-positioned to capitalize on this trend and deliver significant value to patients, providers, and shareholders. The company’s leadership team expresses strong confidence in its ability to continue its growth trajectory and solidify its position as a leading provider of home- and community-based healthcare services.
The company’s success will depend on its ability to effectively integrate the acquired assets, leverage technology, and adapt to the changing healthcare landscape. Ongoing monitoring of regulatory changes, reimbursement policies, and market trends will be crucial. BrightSpring’s proactive approach to innovation and its commitment to providing high-quality care will be key to navigating these challenges and achieving its long-term goals. The company’s focus on both hospice and home health allows it to offer a comprehensive continuum of care, meeting the diverse needs of patients and families.
BrightSpring Health Services will next report its first-quarter 2026 earnings in late April 2026. Investors and industry observers will be closely watching for updates on the integration of the Amedisys and LHC Group assets, as well as further insights into the company’s growth strategy. We encourage readers to share their thoughts and experiences with home health and hospice care in the comments below.
Worth a look